Thursday, 24 Jul 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • VIDEO
  • ScienceAlert
  • White
  • Watch
  • Trumps
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > New Vaccine Shows Promise For Kidney Cancer
Health and Wellness

New Vaccine Shows Promise For Kidney Cancer

Last updated: February 6, 2025 12:34 am
Share
New Vaccine Shows Promise For Kidney Cancer
SHARE

New Cancer Vaccine Shows Promise in Treating Kidney Cancer

A groundbreaking treatment approach for kidney cancer has demonstrated significant success in a phase I clinical trial, offering hope for patients battling this challenging disease.

Recently published in Nature, the results of a trial conducted at Dana-Farber Cancer Institute in Boston, MA have revealed that all nine patients who received the personalized immunotherapy treatment, known as a cancer vaccine, remain cancer-free three years post-treatment.

Unlike traditional vaccines that prevent infectious diseases, cancer vaccines are designed to stimulate the immune system to target and destroy cancer cells in individuals already diagnosed with cancer. While previous cancer vaccines have shown promise in various tumor types, this trial marks a significant breakthrough in the treatment of kidney cancer, a disease known for its high recurrence rate and challenging nature.

In this particular trial, patients underwent surgery to remove the bulk of their tumors, after which samples were analyzed to create a personalized cancer vaccine targeting neoantigens, specific characteristics of the tumor that can trigger an immune response. The vaccine was then administered to help the immune system identify and eliminate any remaining cancer cells.

Dr. David A. Braun, the lead author of the study, emphasized the unique approach of this vaccine, stating, “We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively ‘steered’ towards the cancer in a very specific way.” The long-lasting immune responses generated by this treatment hold promise for preventing tumor recurrence.

While the trial’s sample size is small, the fact that all patients remained cancer-free three years after treatment is a positive indicator, especially for individuals with advanced kidney cancer at high risk of recurrence. Unlike traditional chemotherapy, which may only provide temporary benefits, immunotherapies like cancer vaccines train the immune system to recognize and attack tumor cells long-term, reducing the likelihood of cancer resurgence.

See also  FDA approves first at-home flu vaccine in U.S., a nasal spray

Moreover, the absence of significant side effects reported in the trial is another encouraging aspect of this treatment approach. Dr. Braun believes that this research lays the groundwork for further development of neoantigen vaccines in kidney cancer, paving the way for improved outcomes and reduced side effects in the future.

TAGGED:cancerkidneypromiseShowsvaccine
Share This Article
Twitter Email Copy Link Print
Previous Article California community is sliding toward the Pacific Ocean California community is sliding toward the Pacific Ocean
Next Article Brute accused of killing NYC dad with random knockout punch charged with manslaughter: cops Brute accused of killing NYC dad with random knockout punch charged with manslaughter: cops
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Fox News analyst Gianno Caldwell still seeking justice for brother killed in Chicago three years ago

Fox News political analyst Gianno Caldwell has been seeking answers for nearly three years since…

May 14, 2025

La Liga standings: Will Barcelona clinch the title this week after massive El Clasico comeback vs. Real Madrid

Spain's La Liga is heating up as it enters the final phase of the season,…

May 12, 2025

14 million lives could be lost due to Trump’s USAID cuts : Goats and Soda : NPR

On April 24, Kenyan pharmacist Joseph Njer Airo inspects boxes of antiretroviral drugs labeled "USAID,"…

July 1, 2025

Ladd McConkey’s wife Sydney swoons over WR’s first look in new Chargers jersey ahead of 2025 NFL season

Los Angeles Chargers wide receiver Ladd McConkey recently took to social media to showcase the…

July 17, 2025

Alec Baldwin Suffers Fresh Career Blow After Losing Hosting Job

Alec Baldwin Faces Career Setback, Replaced by Martin Short Recent reports from RadarOnline.com have shed…

April 30, 2025

You Might Also Like

Dispatch Bio raises 6 million for solid tumor immunotherapy
Health and Wellness

Dispatch Bio raises $216 million for solid tumor immunotherapy

July 24, 2025
Hidden benefit in Kennedy push for med school nutrition training
Health and Wellness

Hidden benefit in Kennedy push for med school nutrition training

July 24, 2025
Concern About AI Girlfriends And Digital Fantasies Of Emerging Adults
Health and Wellness

Concern About AI Girlfriends And Digital Fantasies Of Emerging Adults

July 23, 2025
Landmark genome study fills DNA gaps in boost to precision medicine
Health and Wellness

Landmark genome study fills DNA gaps in boost to precision medicine

July 23, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?